Johnson To Hotline 'Right To Try' Bill; FDA Urges Industry Transparency Instead

September 22, 2016 at 6:08 PM
Sen. Ron Johnson (R-WI) plans to ask the Senate to pass through unanimous consent next week his bill barring the federal government from interfering with states' Right To Try laws and providing liability shields to drug makers that provide patients experimental drugs. But an FDA official told lawmakers Thursday (Sept. 22) that a better path forward would be to make pharmaceutical companies' policies more transparent under the current expanded access program, as called for in the House-passed 21st Century Cures...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.